Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Gerardo Ramírez-Nava"'
Autor:
Pedro Cruz-Nova, Brenda Gibbens-Bandala, Alejandra Ancira-Cortez, Gerardo Ramírez-Nava, Clara Santos-Cuevas, Myrna Luna-Gutiérrez, Blanca Ocampo-García
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
IntroductionMore than 1.9 million new cases of colorectal cancer and 935,000 deaths were estimated to have occurred worldwide in 2020. Therapies for metastatic colorectal cancer include cytotoxic chemotherapy and targeted therapies in multiple lines
Externí odkaz:
https://doaj.org/article/40823603a990461e9856085094bdbe1f
Autor:
Luis Coria-Domínguez, Paola Vallejo-Armenta, Myrna Luna-Gutiérrez, Blanca Ocampo-García, Brenda Gibbens-Bandala, Francisco García-Pérez, Gerardo Ramírez-Nava, Clara Santos-Cuevas, Guillermina Ferro-Flores
Publikováno v:
Pharmaceuticals, Vol 15, Iss 5, p 590 (2022)
Tumor microenvironment fibroblasts overexpress the fibroblast activation protein (FAP). We recently reported the preclinical evaluation of [99mTc]Tc-iFAP as a new SPECT radioligand capable of detecting FAP. This research aimed to evaluate the kinetic
Externí odkaz:
https://doaj.org/article/ea81d4c1c2ba436a9e74773c7fb4da5c
Autor:
Myrna Luna-Gutiérrez, Blanca Ocampo-García, Nallely Jiménez-Mancilla, Alejandra Ancira-Cortez, Diana Trujillo-Benítez, Tania Hernández-Jiménez, Gerardo Ramírez-Nava, Rodrigo Hernández-Ramírez, Clara Santos-Cuevas, Guillermina Ferro-Flores
Publikováno v:
Pharmaceutics, Vol 14, Iss 4, p 720 (2022)
Prostate-specific membrane antigen (PSMA) is expressed in a variety of cancer cells, while the fibroblast activation protein (FAP) is expressed in the microenvironment of tumors. Previously, we reported the ability of iPSMA and iFAP ligands to specif
Externí odkaz:
https://doaj.org/article/d5e27cbe70204138936f23e93a9becab
Autor:
Brenda Gibbens-Bandala, Enrique Morales-Avila, Guillermina Ferro-Flores, Clara Santos-Cuevas, Myrna Luna-Gutiérrez, Gerardo Ramírez-Nava, Blanca Ocampo-García
Publikováno v:
Polymers, Vol 11, Iss 10, p 1572 (2019)
The peptide-receptor radionuclide therapy (PRRT) is a successful approach for selectively delivering radiation within tumor sites through specific recognition of radiolabeled peptides by overexpressed receptors on cancer cell surfaces. The efficacy o
Externí odkaz:
https://doaj.org/article/72040da3ec0c4e50bcb9c85274da9ca0